Needham raised the firm’s price target on Globant (GLOB) to $265 from $245 and keeps a Buy rating on the shares after its Q3 results. The company saw healthy organic FX-neutral growth of 9% Y/Y as it continues to gain market share and sign new deals, with most of its regions and verticals growing sequentially, the analyst tells investors in a research note. Recovery in demand is broadening out, and this bodes well for FY25, with management indicating that it expects modest organic growth improvement next year, Needham adds.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.